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Abstract
Aim The aim of this study was to evaluate temporal trends
in treatment and outcome in rectal cancer diagnosed during
1980–2004 at Levanger Hospital.
Materials and methods A protocol for prospective registra-
tion of rectal cancer treated with total mesorectal excision
including operative strategy, radiotherapy and surveillance
was established at Levanger Hospital in 1980. In this study,
all rectal cancer patients treated during 1980–2004 were
included.
Results More patients received preoperative radiotherapy
during 2000–2004, but otherwise there were no significant
differences in presentation or treatment during 1980–2004. The
5-year local recurrence rate after resection with curative intent
was 4.5% (0–9.7), 18.7% (10.3–27.1) and 2.2% (0–6.7) in
1980–1989, 1990–1999 and 2000–2004 (p=0.006), respec-
tively. Out of a total of 23 cases of local recurrence, treatment
guidelines, mainly with regard to radiotherapy, were violated
in 19 cases. The 5-year overall survival after resection with
curative intent was 65% (95% confidence interval [CI] 55–76)
during 1980–1989, 58% (49–68) in 1990–1999 and 71% (59–
83) in 2000–2004 (n.s). The 5-year relative survival was 83%
(95% CI 69–95) during 1980–1989, 71% (59–81) in 1990–
1999 and 84% (69–98) in 2000–2004 (n.s).
Conclusion Rectal cancer patients experienced excellent
outcomes in the period 1980–1989 and 2000–2004. Due to
violations of treatment guidelines, the rate of local
recurrence was much too high in the period 1990–1999.
This article illustrates the importance of continuous quality
assurance in the treatment of rectal cancer to maintain
optimized outcomes for the patients.
Keywords Rectal cancer Guidelines.Quality assurance.
Outcome
Introduction
Total mesorectal excision (TME) as described by Heald et
al. in 1982 has [1] become the gold standard of rectal
cancer surgery. When performed meticulously, it yields low
rates of local recurrence (LR) and improved survival [1]. In
Norway, a national rectal cancer project was launched in
1993 in order to improve outcome for rectal cancer patients.
Of several interventions, TME was introduced as the
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which included training courses and master classes, was
implemented throughout Norway [2]. As a result, the risk
of LR was decreased by 50% [3].
At Levanger Hospital, the modern principles of rectal
cancer surgery were introduced in 1980, and a prospective
protocol for operative strategy, radiotherapy and surveil-
lance was established. Although excellent results were
reported [4], an offer to participate in the TME educational
programme was rejected by Levanger Hospital because it
was a common belief among our staff that we had mastered
this technique. However, the first biannual report from the
Cancer Registry of Norway in 1997 revealed an unaccept-
ably high rate of LR at Levanger hospital, and actions had
to be taken. The protocol was regarded as sufficient and left
unchanged, but the focus on adequate preoperative assess-
ment to assign the right patients to neoadjuvant therapy was
increased. In addition, the team of surgeons who performed
TME surgery was strengthened by having specialists in
colorectal surgery present during operation. In this study, a
complete cohort of patients who were treated for rectal
cancer at Levanger Hospital during 1980–2004 was
analyzed to assess temporal trends in treatment and
oncologic outcomes. We examined every case of LR in
this time period in search of possible protocol violations.
Patients and methods
A complete cohort was assured by using data from the
Norwegian Cancer Registry. The hospital health records of
all patients treated for rectal cancer at Levanger Hospital
from 1980 to the end of 2004 were reviewed. The patients
were assigned into three separate periods, which depended
on their date of surgery: 1980–1989, 1990–1999 and 2000–
2004. The hospital served a defined patient catchment area
with a population that increased slightly from 85,741 in
1980 to 88,858 in 2004.
Theupperlimitforrectalcancerwasdefinedas15cmfrom
the anal verge measured on rigid proctoscopy. The surgery
was performed by sharp dissection under visual guidance in
the avascular plane surrounding the mesorectal fascia. A
major resection with curative intent implied resection of the
tumourbearingsegmentofrectumwithnosignsofmetastases
on preoperative investigations or by intraoperative examina-
tion, but included patients with microscopically involved
margin and intraoperative perforations. The operation was
considered curative if a microscopically free margin was
confirmed and there was no bowel perforation. Circumferen-
tial resection margin (CRM) was defined as the shortest
distance from the periphery of the tumour or tumour deposits
to the resection margin. Residual tumour stage (R stage) was
registered where no residual tumour locally was classified as
R0 resection, microscopically involved margin as R1 resec-
tion and macroscopically residual tumour as R2 resection. To
assign cancer stage we used the TNM Classification of
Malignant Tumours, sixth edition [5]. A histological exam-
ination was missing in 17 patients, of which 12 had received
best supportive care without any operation and five had
received nonresective procedures.
The staff of specialist surgeons was stable and increased
over the past 25 years. During the years 1990–1999, many
undergraduates were responsible for the preoperative exami-
nations, although they performed the surgical procedures
together with a specialist in gastrointestinal surgery. The
responsibility for treatment of rectal cancer was dispersed on
more persons than during 1980–1989. Since 2000, rectal
cancersurgerywasnolongerrequiredforsurgeonsspecializing
in general surgery, and more dedicated teams were responsible
for the preoperative examinations and the treatment.
During the operation, the routine was 5 cm distal margin
for tumours in the upper and middle rectum, but a 2-cm
margin was accepted in lower tumours in order to avoid
abdominoperineal resection.
The clinical follow-up programme after resection with
curative intent was 5 years (range of follow-up 0–28.7 years),
andthemedianfollow-upwithregardtosurvivalwas9.4years
(range 5.0–28.7). The surveillance programme was principal-
ly the same for all 25 years, based on symptoms, clinical
examination including proctoscopy, measure of carcinoem-
bryonic antigen at every visit, chest radiography and colono-
scopy at intervals. Liver ultrasound and CT scan were
performed at intervals as these modalities became available.
LR was defined as recurrent disease in the pelvis or the
perineum,regardlessofwhether itwasdistantmetastasisornot.
Mortality data were collected from the hospital patient
administrative system. Postoperative mortality was defined as
all deaths within 30 days after laparotomy or during the same
hospital stay, regardless of time. Overall survival was estimated
by inclusion of death from any cause. Relative survival was
definedastheratioofobservedsurvivalinrectalcancerpatients
to the expected survival of the general population of Norway.
Perioperative radiotherapy and operative strategy
Preoperative radiotherapy was recommended for patients
who had been diagnosed with locally advanced tumours
throughout the period, initially given as 46 Gy, and in later
years as 2 Gy×25 with concomitant tumour-sensitizing 5-
Fluorouracil. In 1980–1999, before the era of MRI, a
tumour was considered locally advanced when it was fixed
in the pelvis, or if it could not be moved in two planes at
the preoperative examination. The surgery was performed
according to the principles described by Bjerkeset and Edna
[4]. Postoperative radiotherapy was recommended in cases
of an R1 resection or perforation.
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Two by two tables were analyzed using the unconditional z-
pooled test, which is the unconditional version of Pearson’s
χ
2 test [6]. The exact Cochran–Armitage test was used for
testing trends in proportions. The medians of three samples
were analyzed using the Kruskal–Wallis test. To analyze the
association between the period of treatment as an explana-
tory variable and the dependent variables tumour stage, ASA
score and the number of specialists in colorectal surgery, we
used a proportional odds logistic regression model, also
called ordinal logit model, which has been recommended by
Agresti [7]. Kaplan–Meier survivor functions, with
corresponding estimates and 95% confidence intervals (CI),
were calculated. The survival functions were compared using
the log-rank test.
Relative survival was estimated using actuarial methods
and analyzed with STATA [8]. Significance tests of excess
mortality were done using a full likelihood approach.
Norwegian population survival probabilities for every year
from 1980, by sex and age, were downloaded from the
Human Mortality Database [9]. Data were not available for
2009, and according to standard practice, we made the
assumption that the probabilities for 2009 were the same as
for 2008.
Two-sided p values <0.05 were considered significant.
The analyses were performed using SPSS 15.0, STATA 10.0
and StatXact 8.0.
The study was approved by the Regional Committee of
Ethics and performed according to the Helsinki declaration.
Results
A total of 394 patients, 247 males and 147 females, were
treated between 1980 and 2004. The median age at
diagnosis was 69.9 years (range 37–90) during 1980–
1989 and 70.1 years in 1990–1999 and 2000–2004 (range
35–93 and 44–91, respectively).
Location
A total of 125 tumours (32%) were located 12–15 cm from
the anal verge, 175 (44%) were 6–11 cm from the anal
verge and 94 (24%) were 0–5 cm from the anal verge. The
percentage of patients with a low rectal cancer was the
same during the three periods studied.
Presentation
The type of presentation by time period is shown in Table 1.
The number of patients admitted as emergency cases with
either obstruction or spontaneous tumour perforation was
4% (5/127) during 1980–1989, 6% (10/177) in 1990–1999
and 4% (4/90) in 2000–2004. The stage at diagnosis was
similar for all three periods (Table 2). Poor differentiation
was reported in 13% of all rectal cancer cases in1980–1989
and 14% in both 1990–1999 and 2000–2004.
Treatment
Type of treatment in relation to time period is shown in
Table 3. Resection with curative intent was performed in
63.8% (81/127) of all rectal cancer cases during 1980–1989,
64.9% (115/177) in 1990–1999, and 62.2% (56/90) in 2000–
2004 (n.s.). For patients who had a resection with curative
intent, radiotherapy was given preoperatively or postopera-
tively as presented in Table 4. Significantly more patients
received preoperative radiotherapy during 2000–2004.
The rate of resections with curative intent performed
with a specialist in colorectal surgery present increased
significantly from the first to the last time periods (Table 5).
A surgical trainee performed the operation in 37% (30/81)
of all cases during 1980–1989, 44% (51/115) in 1990–1999
and 12.5% (7/56) in 2000–2004 (p=0.011).
The median operative time in operations with curative
intent was 200 min (range 125–410) during 1980–1989,
165 min (84–370) during 1990–1999 and 150 min (67–
310) during the last period (p=0.002).
The median blood loss during operations with curative
intent was 1,200 ml (300–9,000) during 1980–1989,
900 ml (200–10,000) during 1990–1999 and 650 ml (50–
3,000) during the last period (p<0.001).
The proportion with distal resection margin of 2 cm or
more in operations with curative intent was 68% (55/81)
during 1980–1989, 70% (81/115) during 1990–1999 and
84% (47/56), during 2000–2004 (p=0.056).
Sphincter-sparing surgery was performed in 64% (52/81)
of resections with curative intent during 1980–1989, 73%
(84/115) in 1990–1999 and 66% (37/56) in 2000–2004.
Type of presentation 1980–1989 1990–1999 2000–2004 Total
Obstruction without perforation 0 (0) 7 (4) 2 (2) 9 (2)
Spontaneous perforation 5 (4) 3 (2) 2 (2) 10 (3)
Elective presentation 122 (96) 167 (94) 86 (96) 375 (95)
Total 127 (100) 177 (100) 90 (100) 394 (100)
Table 1 Type of presentation in
relation to period (%)
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1980–1989, 6% (5/84) in 1990–1999 and 8% (3/37) in
2000–2004.
Postoperative mortality
After resection with curative intent, the postoperative
mortality rate was 7.4% (6/81) during 1980–1989, 4.3%
(5/115) in 1990–1999 and 3.6% (2/56) in 2000–2004 (p=
0.34). For patients treated with palliative intent, the
corresponding numbers were 8.3% (2/24), 19.4% (7/36)
and 0% (0/20). The overall postoperative mortality was
24% in patients presenting with spontaneous perforation or
bowel obstruction.
Local recurrence
The 5-year estimated LR rate after resection with curative
intent was 4.5% (0–9.7), 18.7% (10.3–27.1) and 2.2% (0–
6.7) in 1980–1989, 1990–1999 and 2000–2004 (p=0.006),
respectively. Out of 11 resections with curative intent,
classified as R1 resections, ten patients developed LR
(Table 6). After curative resection with a distal clearance of
less than 2 cm, LR developed in 11% (10/92) compared to
only 3% (4/138) when the distal clearance was >2 cm (p=
0.014). Out of ten patients with R1 resections and four
patients with intraoperative tumour perforation who later
developed LR, only one patient received postoperative
RT. Radiotherapy was only given to one of the 23
patients who later developed an LR. When no obvious
risk factor was present (T1-3 cancer, no perforation, no
R1 resection or distal clearance >2 cm), only four
patients developed an LR.
Long-term survival
For all stages together, the estimated 5-year overall survival
was 48% (95% CI 40–58) during 1980–1989, 40% (33–48)
in 1990–1999 and 50% (40–61) in 2000–2004 (n.s). The
corresponding estimated 5-year overall survival after
resection with curative intent was 65% (95% CI 55–76)
during 1980–1989, 58% (49–68) in 1990–1999 and 71%
(59–83) in 2000–2004 (n.s). For all stages together, the
estimated 5-year relative survival was 63% (95% CI 51–73)
during 1980–1989, 50% (41–58) in 1990–1999 and 59%
(46–71) in 2000–2004 (n.s.). The corresponding estimated
5-year relative survival after resection with curative intent
was 83% (95% CI 69–95) during 1980–1989, 71% (59–81)
in 1990–1999 and 84% (68–97) in 2000–2004 (n.s).
Discussion
Excellent overall survival, relative survival and LR rates
were achieved in 1980–1989 and 2000–2004. However,
during 1990–1999, the LR rate was unacceptably high and
survival was correspondingly low. In almost all cases of
LR, violation of treatment guidelines could be identified.
This paper presents one of the longest running experi-
ences with TME for rectal cancer. A complete cohort of
patients was obtained, thereby avoiding selection bias. A
protocol for treatment and surveillance was established in
1980 and was unchanged throughout the study period.
Table 2 Stage in relation to period (%)
Stage 1980–1989 1990–1999 2000–2004 Total
I 26 (21) 25 (14) 16 (18) 67 (17)
II 32 (25) 53 (30) 23 (26) 108 (27)
III 32 (25) 44 (25) 19 (21) 95 (24)
IV 22 (17) 34 (19) 24 (27) 80 (20)
Unknown 15 (12) 21 (12) 8 (9) 44 (11)
Total 127 (100) 177 (100) 90 (100) 394 (100)
Association between known stage and period of treatment: OR = 1.17
(0.90–1.51), p=0.24
Table 3 Type of treatment in relation to period (%)
Type of treatment 1980–1989 1990–1999 2000–2004 Total
Best supportive care, no operation 12 (9) 22 (12) 10 (11) 44 (11)
Nonresective procedure: Stoma, bypass, explorative laparotomy, or laparoscopy 7 (6) 14 (8) 9 (10) 30 (8)
Palliative resections 17 (13) 22 (12) 11 (12) 50 (13)
Local resection (trans-anal/endoscopic) 10 (8) 4 (2) 4 (4) 18 (5)
Major resection with curative intent
Involved CRM without bowel perforation 0 (0) 8 (5) 0 (0) 8 (2)
R0 resection and bowel or tumour perforation 4 (3) 5 (3) 2 (2) 11 (3)
Involved CRM and perforation 2 (2) 1 (1) 0 (0) 3 (1)
Curative resection 75 (59) 101 (57) 54 (60) 230 (58)
Total 127 (100) 177 (100) 90 (100) 394 (100)
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registration, this study still has the limitations of a
retrospective study in that the data were analyzed retro-
spectively. This is a minor concern considering that overall
survival and relative survival are robust parameters [10],
although this might have led to underestimation of LR
rates. For instance, old and fragile patients received less
follow-up, which could result in LR being undisclosed.
However, half of all cases with LR were diagnosed in
patients older than 75 years.
The results were significantly worse during 1990–1999,
as can be seen by the estimated 5-year LR rates: 4.5%
during 1980–1989, 18.7% in 1990–1999 and 2.2% in
2000–2004 after resections with curative intent. In order to
understand why LR occurred, all cases of LR were
analyzed with particular emphasis on whether the protocol
outlined in 1980 had been followed. Preoperative radio-
therapy was recommended in locally advanced cases to
achieve R0 resections. However, none of the four patients
with a stage T4 cancer who later developed LR received
preoperative radiotherapy. During 2000–2004, significantly
more patients received preoperative radiotherapy, and
excellent results concerning LR were achieved.
The CRM is a strong predictor of LR, distant metastasis
and survival [11–13] in rectal cancer. The main reason why
TME has been so successful in lowering LR rates compared
to traditional rectal resections is its ability to achieve R0
resections [14]. In a recent publication [15], a CRM <2 mm
was associated with poorer prognosis. In this study, we
found that in a total of 11 R1 resections with curative intent,
out of which nine where operated on during 1990–1999, ten
patients later developed LR. Only one of these ten patients
received postoperative radiotherapy. Although recommen-
ded in our protocol, Marijnen et al. [16] found little
evidence to support postoperative radiotherapy as this was
of no benefit for patients receiving non-radical resections.
On the other hand, preoperative radiotherapy was effective
in cases of narrow margins (1.1–2 mm) and wider margins.
Knowing this, selecting patients at risk for R1 resections for
preoperative radiotherapy to achieve R0 resections is far
more important than offering postoperative radiotherapy to
patients with microscopically involved margin.
Intraoperative perforation during resection of rectal
cancer increases the LR rate and reduces survival [17,
18]. Although this remains to be proven effective in this
setting [17], postoperative radiotherapy was recommended
in our protocol and has since been implemented in both
Norwegian and American guidelines [19, 20]. There is no
upper age limit for adjuvant radiotherapy in Norway, but
individual considerations must be taken for those aged
above 75 years as radiotherapy substantially increases the
risk of death from causes unrelated to rectal cancer in this
age group [21]. Out of four patients with tumour perfora-
tion, three did not receive postoperative radiotherapy, all
aged above 80 years.
Although there is conflicting evidence concerning how
long the distal margin should be in resections of rectal
cancers, many researchers [20, 22] recommend a distal
clearance of >2 cm in AR, which is recommended in our
protocol. The rationale underlying this is the finding that
intramural spread from rectal cancers >1 cm from the
primary lesion is uncommon [23] and even more so if the
patient has been subject to preoperative RT [24]. In the
present study, significantly more patients developed LR
with a distal clearance of less than 2 cm. Furthermore, none
of these patients had received neoadjuvant RT. In a total of
15 patients with distal clearance <2 cm and LR, 13
underwent operation during 1990–1999. In surgery of low
rectal cancers, there is often a dilemma concerning
oncologic radicality and the avoidance of stomas. This
study supports the view that a distal clearance of at least
2 cm should be given priority and in cases where this is
1980–1989 1990–1999 2000–2004 Total
No radiotherapy 73 (90.1) 111 (96.5) 41 (73.2) 225 (89.3)
Preoperative radiotherapy 5 (6.2) 1 (0.9) 12 (21.4) 18 (7.1)
Postoperative radiotherapy 2 (2.5) 3 (2.6) 3 (5.4) 8 (3.2)
Preoperative and postoperative radiotherapy 1 (1.2) 0 (0) 0 (0) 1 (0.4)
Total 81 (100) 115 (100) 56 (100) 252 (100)
Table 4 Radiotherapy for
patients treated with curative
intent (%)
p=0.008 (Cochran–Armitage
trend test of radiotherapy vs. no
radiotherapy)
Number of specialist surgeons 1980–1989 1990–1999 2000–2004 Total
0 17 (21) 1 (0.9) 0 (0) 18 (17.1)
1 60 (74.1) 91 (79.1) 20 (35.7) 171 (67.9)
2–3 4 (4.9) 23 (20) 36 (64.3) 63 (25)
Total 81 (100) 115 (100) 56 (100) 252 (100)
Table 5 Number of specialist
surgeons (%) attending resec-
tions with curative intent
Association between number of
specialist surgeons and period of
treatment: OR=7.7 (95% CI
4.7–12.9), p<0.001
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preoperative RT should be considered.
The number of specialists in colorectal surgery present at
operationincreasedduringtheyearsofthepresentstudy.After
theyear2000,rectalcancersurgerywasnolongerrequiredfor
surgeonswhoarespecialistsingeneralsurgeryinNorway,and
the number of operations performed by a trainee was
significantly reduced. The current policy at Levanger Hospital
is that rectal cancer resections should be performed by or
under the supervision of a specialist surgeon and having two
specialists present is recommended. Borowski et al. [25]
found no difference in anastomotic leak rates, operative
mortality or survival between unsupervised trainees, super-
vised trainees and consultants. We still believe that the
introduction of more competent teams performing the
surgery has contributed to better results during 2000–2004.
The better results during 1980–1989 compared to 1990–
1999 are perhaps dependent on there being far more
experienced trainees working at the hospital during the first
period. During the 1980s, the trainees were more experi-
enced in general surgery (6–11 years experience) than the
surgeons in the 1990s (3–6 years experience).
Preoperative radiotherapy at biologically effective doses
≥30 Gy has been shown to reduce the risk of LR and death
from rectal cancer, and postoperative radiotherapy has been
shown to reduce the risk of LR [21]. Preoperative chemo-
radiation is even more effective in lowering the LR rate,
and an additional effect on survival is possible [26]. At
Levanger Hospital, adjuvant radiotherapy has been recom-
mended since 1980, but was barely used during 1990–
1999, which may explain why the rate of LR was high and
survival correspondingly low during these years. For the
years 2000–2004, when the LR rate and survival were
excellent, 21% received preoperative radiotherapy. If the
quality of surgery performed was evaluated by operative
time, blood loss, the proportion with sphincter-sparing
surgery, by the proportion without postoperative anasto-
motic leakage and by the proportion with a resection
margin of at least 2 cm, the quality of the surgery performed
for curative intent did not seem to be inferior during 1990–
1999 compared with 1980–1989. Even if experienced
surgeons assisted the many surgical trainees during the
operations, and the operations were adequate, the ultimate
outcome was inferior for some patients during 1990–1999,
Table 6 Operative characteristics and radiotherapy in patients with local recurrence after resection with curative intent
Sex and
age
Year T-stage + Nodes CRM >2 mm Level of
tumour
Distal
margin >2 cm
R status Perforation
of tumour
Preoperative
radiotherapy
Postoperative
radiotherapy
♀ 84 1984 4 Y N Middle Y 1 Y N N
♀ 58 1984 4 Y N Middle Y 1 Y N Y
♀ 83 1985 3 Y UK Lower Y 0 N N N
♂ 62 1989 2 N UK Middle N 0 N N N
♀ 75 1990 3 Y UK Middle N 0 N N N
♂ 72 1991 3 N UK Upper N 0 N N N
♀ 73 1991 3 N UK Lower Y 0 N N N
♀ 79 1991 4 Y N Middle Y 1 N N N
♂ 74 1992 3 N UK Middle N 0 N N N
♂ 72 1993 3 Y N Upper N 1 N N N
♀ 70 1993 2 N Y Middle N 0 N N N
♀ 76 1993 3 Y N Upper Y 1 N N N
♂ 73 1994 3 N N Middle N 1 N N N
♂ 81 1995 1 N UK Upper N 0 Y N N
♂ 52 1997 3 N N Upper N 1 N N N
♀ 79 1997 4 Y N Lower N 1 N N N
♂ 84 1998 3 Y Y Lower Y 0 N N N
♀ 62 1998 3 Y Y Middle Y 0 N N N
♂ 59 1999 2 N UK Middle N 0 N N N
♂ 75 1999 3 N N Middle N 1 N N N
♂ 74 1999 3 Y Y Middle N 0 N N N
♀ 78 1999 3 N N Middle N 1 N N N
♂ 85 2003 3 Y Y Upper N 0 Y N N
Level of tumour — distance from the anal verge: 12–15 cm, upper rectum; 6–11 cm, middle rectum, <6 cm, lower rectum
Y yes, N no, UK unknown
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radiotherapy. In many cases, the preoperative judgment
concerning radiotherapy failed during 1990–1999. From
year 2000, dedicated teams took care of preoperative
evaluation and surgery, and the introduction of preoperative
MRI for all patients with cancer of the rectum from this
time on, made it possible with a much better and objective
selection of those who needed preoperative radiotherapy.
In the present study, the estimated 5-year overall survival
after resection with curative intent was 65% (95% CI 55–76)
during1980–1989,58%(49–68)in1990–1999and71%(59–
83) in 2000–2004 (n.s). A higher rate of LR during 1990–
1999 was accompanied by a lower survival rate. The negative
prognostic effect of LR on survival is well documented [2].
Conclusions
Excellent results were seen during the 1980s due to the
implementation of modern principles of rectal cancer treat-
mentatLevangerHospitalin1980.However,reportsfromthe
nationalrectalcancerregistryrevealedpoorresultsforpatients
treated in Levanger during the 1990s, and the current paper
discloses that violations of the treatment guidelines, particu-
larly with respect to radiotherapy for patients with advanced
stages, had serious effects on patient prognosis during these
years. Actions were taken to improve compliance regarding
treatment guidelines for rectal cancer and to strengthen the
surgical teamwhichtookcareofthe patientspreoperativelyas
well as performed the TME surgery. During 2000–2004, the
results wereonceagainexcellent. Thepresent studyillustrates
that althoughtreatment guidelinesand surgical technique may
be adequate, continuous focus on quality assurance and the
collective effortsofthe membersofthe multidisciplinaryteam
are mandatory to maintain optimized outcomes for rectal
cancer patients.
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